Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.

被引：0
|
作者：
Pirker, R
Jaeger, U
Pohl, G
Stranzl, T
Simonitsch, I
Kaider, A
Skrabs, C
Filipits, M
机构：
[1] Univ Vienna, Dept Internal Med 1, Vienna, Austria
[2] Univ Vienna, Inst Clin Pathol, Vienna, Austria
[3] Univ Vienna, Dept Med Comp Sci, Vienna, Austria
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
528
引用
收藏
页码：126A / 126A
页数：1
相关论文
共 50 条
  • [41] Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma
    Park, Jeayeon
    Chung, Sung Won
    Lee, Yun Bin
    Shin, Hyunjae
    Hur, Moon Haeng
    Cho, Heejin
    Park, Min Kyung
    Youk, Jeonghwan
    Lee, Ji Yun
    Lee, Jeong-Ok
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Kim, Tae Min
    Lee, Jeong-Hoon
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (03) : 794 - 809
  • [42] Dual Translocation Is An Independent Poor Prognostic Factor in Diffuse Large B-Cell Lymphoma
    Tay, Kevin
    Lai, Gillianne
    Chua, Elaine J.
    Ong, Whee Sze
    Tang, Tiffany
    Quek, Richard
    Tan, Daryl
    Tan, Leonard
    Tao, Miriam
    Tan, Soo Yong
    Lim, Soon Thye
    BLOOD, 2011, 118 (21) : 1574 - 1574
  • [43] Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma
    Fuertes, Silvia
    Setoain, Xavier
    Lopez-Guillermo, Armando
    Carrasco, Josep-Lluis
    Rodriguez, Sonia
    Rovira, Jordina
    Pons, Francesca
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (04) : 496 - 504
  • [44] Prognostic Value of Fatty Acid Synthase and Spot14 in Diffuse Large B-Cell Lymphoma.
    Danilova, O. V.
    Froehlich, H. M.
    Hammour, T.
    Kuemmerle, N. B.
    Levy, N. B.
    Kinlaw, W. B.
    Kaur, P.
    LABORATORY INVESTIGATION, 2011, 91 : 293A - 293A
  • [45] SECISBP2 is a novel prognostic predictor that regulate selenoproteins in diffuse large B-cell lymphoma.
    Taguchi, Towako
    Yamamoto, Kouhei
    Kinowaki, Yuko
    Onishi, Iichiroh
    Kurata, Morito
    Yamamoto, Masahide
    Kitagawa, Masanobu
    CANCER SCIENCE, 2021, 112 : 832 - 832
  • [46] Diffuse large B-cell lymphoma - Molecular heterogeneity of diffuse large B-cell lymphoma
    Gascoyne, RD
    HEMATOLOGY JOURNAL, 2004, 5 : S144 - S148
  • [47] Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma
    Silvia Fuertes
    Xavier Setoain
    Armando Lopez-Guillermo
    Josep-Lluis Carrasco
    Sonia Rodríguez
    Jordina Rovira
    Francesca Pons
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 496 - 504
  • [48] Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma
    Nobuhiko Nakamura
    Takeshi Hara
    Yuhei Shibata
    Takuro Matsumoto
    Hiroshi Nakamura
    Soranobu Ninomiya
    Yusuke Kito
    Junichi Kitagawa
    Nobuhiro Kanemura
    Naoe Goto
    Makoto Shiraki
    Tatsuhiko Miyazaki
    Tamotsu Takeuchi
    Masahito Shimizu
    Hisashi Tsurumi
    Annals of Hematology, 2015, 94 : 2043 - 2053
  • [49] Prognostic Value of Fatty Acid Synthase and Spot14 in Diffuse Large B-Cell Lymphoma.
    Danilova, O. V.
    Froehlich, H. M.
    Hammour, T.
    Kuemmerle, N. B.
    Levy, N. B.
    Kinlaw, W. B.
    Kaur, P.
    MODERN PATHOLOGY, 2011, 24 : 293A - 293A
  • [50] Prognostic relevance of gene expression using RT-PCR in diffuse large B-cell lymphoma.
    Kim, HN
    Lee, JJ
    Yang, DH
    Kim, YK
    Kim, NY
    Park, KS
    Kim, HJ
    Jang, DY
    Ahn, JS
    Bae, SH
    Ryoo, HM
    Kim, HJ
    BLOOD, 2004, 104 (11) : 224B - 224B
12345